409 Abstracts another 3.6 million are at an increased risk. In men over 64 years of age, 80% of hip fractures are attributed to osteoporosis, costing a national direct expenditure of $13.8 billion in 2000. Earliest diagnosis is through a bone density test, which could help in prevention of hip fractures and significant savings in health care costs. This study examines the various physician and patient factors, which influence the bone density test prescribing for osteoporosis in male ambulatory patients. METHODS: Patient factors such as age, race, geographical location and payment source, and Physician factors such as specialty and referral status were used to determine their influence on the number of bone density tests prescribed. Data from the National Ambulatory Medical Care Survey (NAMCS) 2002 were utilized. Male patients with principal diagnosis of osteoporosis (ICD-9-CM code 733.00) with age more than or equal to 50 years were analyzed using multiple linear and binomial logit regression models. RESULTS: The number of bone density tests performed were independent of patients' geographic region (R 2 = 0.111). White patients were prescribed more bone density tests compared to other races (R 2 = 0.436). Patients above 75 years of age and patients with Federal source of payments were prescribed more bone density tests than other patients (R 2 = 0.345). Numbers of bone density tests were not influenced by whether the patient was referred (R 2 = 0.027). Family Practice physicians prescribed more bone density tests compared to other specialties (R 2 = 0.326). CONCLUSIONS: The numbers of bone density tests prescribed are significantly influenced by patients' race, age and source of payments, and physician's specialty. Bone density screening for men over 50 years of age appears to be an optimal approach to manage osteoporosis in men.
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POST-OSTEOPOROTIC FRACTURE DRUG TREATMENT FOR OSTEOPOROSIS IN NURSING HOME ELDERLY
Ye X, Eberly LE, Harms SL, Garrard JM University of Minnesota, Minneapolis, MN, USA OBJECTIVES: A preexisting fracture is a very strong predictor of subsequent osteoporotic fractures, emphasizing the need to aggressively treat patients with existing osteoporotic fractures. The objectives of the study are to examine the prevalence of drug treatment and factors associated with drug treatment among elderly nursing home (NH) admissions with an indication of osteoporotic fracture. METHODS: The Minimum Data Set for Nursing Home Assessment and Care Screening (MDS) Version 2.0 and physicians' medication orders from 1999 were utilized for this study. The outcome was the use of anti-osteoporotic drug therapy at NH admission. Independent variables included patient demographics, comorbidities, functional capabilities (activities of daily living or ADLs), and cognitive performance (MDS-COGS). Multivariate analysis was conducted using logistic regression with Generalized Estimating Equations (GEE) to adjust for clustering within NH facilities. RESULTS: A total of 2673 NH residents were identified with documentation of osteoporotic fracture within 180 days or affecting current care at admission; however, only 642 (24.02%) received anti-osteoporotic drug therapy at admission. Gender (p < 0.0001), age (p = 0.0394), and functional capabilities (p = 0.0002) were significantly associated with the use of anti-osteoporotic drug. Nonsignificant factors were region, race, education, comorbidity and cognition. Treatment was less likely for male residents (OR: 0.45; 95% CI, 0.33-0.62) and residents older than 85 (OR: 0.79; 95% CI, 0.67-0.97). Those who were independent in terms of ADLs were more likely to receive drug treatment (OR: 2.54; 95% CI, 1.27-5.07), compared to those who were fully dependent. CONCLUSIONS: While osteoporotic fracture is common among the NH elderly population, the majority remained untreated. Increasing age was inversely related to receipt of antiosteoporotic drugs. Female elderly and those with fewer limitations in daily activities were more likely to receive drug therapy for osteoporosis. The OPSAT-Q, Osteoporosis Targeted Quality of Life (OptQoL), three single-item global measures related to satisfaction, and demographic questionnaires were self-administered to eligible women recruited from four US clinics. Participants were diagnosed with osteoporosis or osteopenia and currently taking daily or weekly bisphosphonate treatment. Reproducibility was assessed via a follow-up questionnaire completed by participants two-weeks post baseline. Analyses included item and scale performance, internal consistency reliability, reproducibility, and construct validity. RESULTS: A total of 104 women with a mean age of 65 years participated. The majority was white (64.4%), living with someone (74%), and not currently employed (58.7%). On a scale of 0-100, individual patient subscale scores ranged from 17 to 100 and CSS scores ranged from 44-100. All scores showed acceptable internal consistency reliability (Cronbach's a > 0.70) (range 0.72 to 0.89). Reproducibility exceeded 0.70 for all scores except Confidence with Daily Activity (0.62) and Overall Satisfaction (0.64). Significant correlations were found between the OPSAT-Q subscales and conceptually similar global measures (p < 0.001). CONCLUSIONS: The findings from this study provide evidence of the validity and reliability of the OPSAT-Q and support the proposed composition of four subscales and a composite score. They also support the use of the OPSAT-Q to examine the impact of potentially more convenient bisphosphonate dosing on patient satisfaction.
PAIN PPN1 REDUCING MORTALITY IN PATIENTS WITH SUBSTANCE ABUSE AND CHRONIC NON-MALIGNANT PAIN THROUGH A MULTIDISCIPLINARY OPIOID RENEWAL CLINIC
Sampson JM, Marsh B VA Medical Center, Gainesville, FL, USA OBJECTIVE: Is it safe to treat patients with opioids for chronic non-malignant pain who have histories of substance abuse or addicition? Mortality rates for substance abusers are three times the general population rate. There are few outcome studies in the medical literature. The Opioid Renewal Clinic follows patients closely with drug testing, laboratory monitoring, and provides group education with outside speakers. On site drug counseling is provided to those determined to be in need. A full range of consultation services are available. The disciplines that make up the clinc include Pharmacy, Nursing, Social Work, Internal and Addiction Medicine. Disease management guidelines are incorporated into the structure of the clinic. METHODS: This was a retrospective age adjusted mortality study of 250 Primary Care consults over a two-year period to a multidisciplinary Opioid Renewal Clinic. The most common reason for consultation was the difficult to manage patient secondary to substance abuse. The renewal clinic maintains between 80 to 100 patients. Kaplan-Meier survival curves were performed for pain patients on opioids in Primary Care and the opioid renewal clinic. Key variables were evaluated by regression analysis. RESULTS: There were six deaths in patients in Primary Care and two deaths in patients followed in the Renewal Clinic. The odds ratio of deaths in usual care to clinic is three, or three times the rate of the Renewal Clinic. Patients were between 40-60 years of age. Deaths due to known cancer, cardiac or liver disease were excluded. Cancer deaths were predominantly lung, and assosciated with tobacco use. CONCLUSIONS: A Multidisciplinary Opioid Renewal Clinic can reduce short term mortatlity in high risk patients. Further studies are recommended to assess long term mortality rates and secondary outcomes on cancer prevention, disease management, and control of depression.
